4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001771961-26-000004
Chief Accounting Officer sold 2,562 shares at $25.77 ($66,024)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Azoy Alexander Chief Accounting Officer | 2026-06-01 | Sale 10b5-1 | −2,562 | $25.77 | $66,024 | 39,581 | D: show line 1 in the form |
| Open-market sales · 2,562 sh · avg $25.77 · $66,024 | |||||||
Loading xslF345X06/wk-form4_1780356235.xml…